121 related articles for article (PubMed ID: 20382443)
1. Human prostasomes express CD48 and interfere with NK cell function.
Tarazona R; Delgado E; Guarnizo MC; Roncero RG; Morgado S; Sánchez-Correa B; Gordillo JJ; Dejulián J; Casado JG
Immunobiology; 2011; 216(1-2):41-6. PubMed ID: 20382443
[TBL] [Abstract][Full Text] [Related]
2. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells.
Messmer B; Eissmann P; Stark S; Watzl C
J Immunol; 2006 Apr; 176(8):4646-50. PubMed ID: 16585556
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation affects ligand binding and function of the activating natural killer cell receptor 2B4 (CD244) protein.
Margraf-Schönfeld S; Böhm C; Watzl C
J Biol Chem; 2011 Jul; 286(27):24142-9. PubMed ID: 21606496
[TBL] [Abstract][Full Text] [Related]
4. Regulation of 2B4 (CD244)-mediated NK cell activation by ligand-induced receptor modulation.
Sandusky MM; Messmer B; Watzl C
Eur J Immunol; 2006 Dec; 36(12):3268-76. PubMed ID: 17111350
[TBL] [Abstract][Full Text] [Related]
5. Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions.
Wu Y; Kuang DM; Pan WD; Wan YL; Lao XM; Wang D; Li XF; Zheng L
Hepatology; 2013 Mar; 57(3):1107-16. PubMed ID: 23225218
[TBL] [Abstract][Full Text] [Related]
6. Functional role of human NK cell receptor 2B4 (CD244) isoforms.
Mathew SO; Rao KK; Kim JR; Bambard ND; Mathew PA
Eur J Immunol; 2009 Jun; 39(6):1632-41. PubMed ID: 19499526
[TBL] [Abstract][Full Text] [Related]
7. The association of MHC class I proteins with the 2B4 receptor inhibits self-killing of human NK cells.
Betser-Cohen G; Mizrahi S; Elboim M; Alsheich-Bartok O; Mandelboim O
J Immunol; 2010 Mar; 184(6):2761-8. PubMed ID: 20164429
[TBL] [Abstract][Full Text] [Related]
8. Subversion of natural killer cell responses by a cytomegalovirus-encoded soluble CD48 decoy receptor.
Martínez-Vicente P; Farré D; Sánchez C; Alcamí A; Engel P; Angulo A
PLoS Pathog; 2019 Apr; 15(4):e1007658. PubMed ID: 30947296
[TBL] [Abstract][Full Text] [Related]
9. Prostasomes: extracellular vesicles from the prostate.
Aalberts M; Stout TA; Stoorvogel W
Reproduction; 2014 Jan; 147(1):R1-14. PubMed ID: 24149515
[TBL] [Abstract][Full Text] [Related]
10. Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation.
Morandi B; Costa R; Falco M; Parolini S; De Maria A; Ratto G; Mingari MC; Melioli G; Moretta A; Ferlazzo G
J Immunol; 2005 Sep; 175(6):3690-7. PubMed ID: 16148114
[TBL] [Abstract][Full Text] [Related]
11. Prothrombotic effects of prostasomes isolated from prostatic cancer cell lines and seminal plasma.
Babiker AA; Ekdahl KN; Nilsson B; Ronquist G
Semin Thromb Hemost; 2007 Feb; 33(1):80-6. PubMed ID: 17253194
[TBL] [Abstract][Full Text] [Related]
12. Human choriocarcinoma cell resistance to natural killer lysis due to defective triggering of natural killer cells.
Avril T; Iochmann S; Brand D; Bardos P; Watier H; Thibault G
Biol Reprod; 2003 Aug; 69(2):627-33. PubMed ID: 12724286
[TBL] [Abstract][Full Text] [Related]
13. 2B4 engagement mediates rapid LFA-1 and actin-dependent NK cell adhesion to tumor cells as measured by single cell force spectroscopy.
Hoffmann SC; Cohnen A; Ludwig T; Watzl C
J Immunol; 2011 Mar; 186(5):2757-64. PubMed ID: 21270395
[TBL] [Abstract][Full Text] [Related]
14. Modulation of 2B4 (CD244) activity and regulated SAP expression in human NK cells.
Endt J; Eissmann P; Hoffmann SC; Meinke S; Giese T; Watzl C
Eur J Immunol; 2007 Jan; 37(1):193-8. PubMed ID: 17171759
[TBL] [Abstract][Full Text] [Related]
15. Human natural killer cell receptor 2B4 (CD244) down-regulates its own expression by reduced promoter activity at an Ets element.
Mathew SO; Vaidya SV; Kim JR; Mathew PA
Biochem Biophys Res Commun; 2007 Apr; 355(2):483-7. PubMed ID: 17300754
[TBL] [Abstract][Full Text] [Related]
16. NMR structure of the natural killer cell receptor 2B4 (CD244): implications for ligand recognition.
Ames JB; Vyas V; Lusin JD; Mariuzza R
Biochemistry; 2005 May; 44(17):6416-23. PubMed ID: 15850375
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of antigen-specific immunoglobulin G responses by anti-CD48.
Yuan D; Guo Y; Thet S
J Innate Immun; 2013; 5(2):174-84. PubMed ID: 23208079
[TBL] [Abstract][Full Text] [Related]
18. CD48: A co-stimulatory receptor of immunity.
Elishmereni M; Levi-Schaffer F
Int J Biochem Cell Biol; 2011 Jan; 43(1):25-8. PubMed ID: 20833258
[TBL] [Abstract][Full Text] [Related]
19. A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand.
Costello RT; Sivori S; Mallet F; Sainty D; Arnoulet C; Reviron D; Gastaut JA; Moretta A; Olive D
Leukemia; 2002 May; 16(5):855-60. PubMed ID: 11986947
[TBL] [Abstract][Full Text] [Related]
20. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
